Next Article in Journal
Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
Next Article in Special Issue
Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors—A Retrospective Multi-Center Registry Analysis
Previous Article in Journal
Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use
Previous Article in Special Issue
Looking at Thyroid Cancer from the Tumor-Suppressor Genes Point of View
 
 
Article

Article Versions Notes

Cancers 2022, 14(11), 2639; https://doi.org/10.3390/cancers14112639
Action Date Notes Link
article xml file uploaded 26 May 2022 14:27 CEST Original file -
article xml uploaded. 26 May 2022 14:27 CEST Update https://www.mdpi.com/2072-6694/14/11/2639/xml
article pdf uploaded. 26 May 2022 14:27 CEST Version of Record https://www.mdpi.com/2072-6694/14/11/2639/pdf
article supplementary file uploaded. 26 May 2022 14:27 CEST - https://www.mdpi.com/2072-6694/14/11/2639#supplementary
article html file updated 26 May 2022 14:29 CEST Original file -
article html file updated 3 August 2022 01:59 CEST Update https://www.mdpi.com/2072-6694/14/11/2639/html
Back to TopTop